Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol.
about
Fruit juice inhibition of uptake transport: a new type of food-drug interactionCircadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.Herbal modulation of P-glycoprotein.Relevance of multidrug resistance proteins for intestinal drug absorption in vitro and in vivo.The effect of grapefruit juice on drug disposition.The effect of food components on the absorption of P-gp substrates: a review.Intestinal drug absorption and bioavailability: beyond involvement of single transport function.Antihypertensive therapy: special focus on drug interactions.Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Strategies to improve oral drug bioavailability.Grapefruit-drug interactions: can interactions with drugs be avoided?Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions.Interactions of grapefruit juice and cardiovascular medications: A potential risk of toxicity.Herb-drug pharmacokinetic interactions reviewed.Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.Enzyme- and transporter-mediated beverage-drug interactions: An update on fruit juices and green tea.Cancer chemoprevention through dietary flavonoids: what's limiting?Clinical determinants of calcineurin inhibitor disposition: a mechanistic review.Effect of lyophilized grapefruit juice on P-glycoprotein-mediated drug transport in-vitro and in-vivo.Validated HPLC method for quantitative determination of talinolol in rat plasma and application to a preclinical pharmacokinetic study.Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants.Lack of effect of continuous glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteers.Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening.Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California.Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts.Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants.Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.Modeling the effects of commonly used drugs on human metabolism
P2860
Q24630998-463E571D-41E8-4E32-9DF8-9CB1DA04C933Q34226780-EE363B74-C19D-4F28-B60C-D078A0B4A18FQ34312035-BEFA32B0-08ED-4A2B-BF29-EB04531CF0B8Q34634236-224BE14A-14DA-49E4-A71D-B594951E38C0Q34764136-A4D509A7-D9D7-4390-8476-62E2476D682EQ35083696-BA00C0BF-384B-4B7D-AA64-CDC3D6794DC4Q35153169-158E0AD9-AB11-4F88-BB6A-9B7AD3C6A093Q35570981-3EDC5C61-1949-46DC-9A94-1A7CD79AF984Q35609347-AA5FFB0C-D14C-43BE-82AB-862D896DD1E1Q35876954-4A5C65D8-7B18-43B0-B781-270481E1F1F0Q36316751-51FA1B1D-7064-4A01-B462-E66A67274E10Q36652594-0491DAAD-236E-4295-BFEE-FEED3C2E3AC5Q36725218-ADF7C65B-0179-4AE8-8BBB-8886930BDFDEQ37276411-056E38FF-7223-4A0F-BAAE-AD125BB74996Q37808478-296E9609-5D14-4AA6-951C-266F6761A01EQ38056878-290961C6-AC4D-4101-A2C5-9B79AB6EB602Q38071690-538A088C-78D6-4E82-A663-1522DB6C8A7AQ38202698-1D899B8E-9DBC-4A12-8F64-AEC56967C7CAQ38533636-B48A0FA5-A418-4953-ABDF-1ADB2E10833FQ38718844-8FDCA9C3-68C9-425A-B910-13184B2FC2EFQ38748975-6ACD6629-837A-4076-925B-ED222B19A2B3Q39049238-0746B7DC-F061-4D8C-9142-7A9D185584DDQ42807223-BFC5DB60-C70B-4AB8-B62F-607DB8F2C9D6Q43233462-B15E8A9E-49CE-47A5-B776-45E2EDD43341Q43668673-5FFFB0D2-82AE-4417-BB33-EE62AAE5739DQ44160439-3CAB64CE-BC5B-49EF-BCD2-EB2F0028A27BQ45953187-5C92B20E-528B-4B36-8148-2E02E6A6FF22Q46592717-FF6C70DB-0EA0-4CA4-8DFD-EF7A23B69F34Q46851059-E3C1EB92-75D3-4886-92D2-7CEEA2E3D453Q48228540-57A82CA9-E8DA-4905-8AB2-22ED3C68E2E2Q54681966-2A8510EC-E181-44B1-9C96-FA9550625054Q57004702-27519F9E-81E3-4AF5-8F10-E1B5D2641A6F
P2860
Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Grapefruit juice enhances inte ...... coprotein substrate talinolol.
@ast
Grapefruit juice enhances inte ...... coprotein substrate talinolol.
@en
type
label
Grapefruit juice enhances inte ...... coprotein substrate talinolol.
@ast
Grapefruit juice enhances inte ...... coprotein substrate talinolol.
@en
prefLabel
Grapefruit juice enhances inte ...... coprotein substrate talinolol.
@ast
Grapefruit juice enhances inte ...... coprotein substrate talinolol.
@en
P1476
Grapefruit juice enhances inte ...... coprotein substrate talinolol.
@en
P2093
Langguth P
Spahn-Langguth H
P304
P356
10.1016/S0928-0987(00)00191-3
P407
P577
2001-02-01T00:00:00Z